Clinic Opinions Regarding IUCD Use in Adolescents

Journal of Pediatric and Adolescent Gynecology

Volumn 19, Issue 4, 2006, Pages 301-303

  Lacy, Judith ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ABORTION; ACNE; ADOLESCENT HEALTH; AMENORRHEA; ARTICLE; BLEEDING; CONTRACEPTION; DYSMENORRHEA; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; IRRITABILITY; MENSTRUATION DISORDER; MOOD DISORDER; MULTIPARA; OILY SKIN; PAIN; PRIORITY JOURNAL; SAFETY; SEXUALLY TRANSMITTED DISEASE; WEIGHT GAIN;

EID: 33746218287     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2006.05.013     Document Type: Note

References (7)

1. Piccinino L.J., and Mosher W.D. Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect 30 (1998) 4
2. Spinelli A., Talamanca I.F., and Lauria L. Patterns of contraceptive use in 5 European countries. European Study Group on Infertility and Subfecundity. Am J Public Health 90 (2000) 1403
3. Rotermann M. Sex, condoms and STDs among young people. Health Reports 16 3 (2005) 39
4. Suhonen S., Haukkamaa M., Jakobsson T., et al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69 (2004) 407
5. Andersson K., Odlind V., and Rybo G. Levonorgestrel releasing and copper releasing (Nova T) IUCDs during five years of use. A randomized comparative study. Contraception 49 (1994) 56
6. Luukkainen T., Allonen H., Haukkamaa M., et al. Effective contraception with the levonorgestrel- releasing intrauterine device: 12-month report of a European multicenter study. Contraception 36 (1987) 160
7. Rivera R., Chen-Mok M., and McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUCD. Contraception 60 (1999) 155